Pharmaceutical products in Malaysia are regulated by the National Pharmaceutical Regulatory Agency (NPRA) under the Ministry of Health Malaysia. Malaysia has implemented a national pharmaceutical verification and traceability initiative to improve supply chain transparency and prevent counterfeit medicines.
Malaysia operates the Pharmaceutical Track and Trace System (Pharma T&T), which requires pharmaceutical products to carry GS1 compliant DataMatrix barcodes with serialized identifiers. The system enables tracking and verification of medicines throughout the pharmaceutical supply chain.
The Pharma T&T framework supports digital reporting of medicine movement from manufacturers and importers through distributors to pharmacies. The system aims to improve regulatory oversight, protect patients from falsified medicines, and strengthen the integrity of the pharmaceutical supply chain.
Implementation has been phased, with serialization requirements initially applied to selected pharmaceutical products and progressively expanded.